Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | Abundance Ratio: (Cortex KO) / (Cortex WT) | Abundance Ratio (log2): (Cortex KO) / (Cortex WT) | Abundance Ratio P-Value: (Cortex KO) / (Cortex WT) | Abundance Ratio Adj. P-Value: (Cortex KO) / (Cortex WT) | Abundance Ratio Variability [%]: (Cortex KO) / (Cortex WT) | Abundances (Grouped): Cortex KO | Abundances (Grouped): Cortex WT | Abundances (Grouped) CV [%]: Cortex KO | Abundances (Grouped) CV [%]: Cortex WT | Abundances (Scaled): F1: 129, Sample, Cortex KO, 1 | Abundances (Scaled): F1: 130, Sample, Cortex KO, 2 | Abundances (Scaled): F1: 131, Sample, Cortex KO, 3 | Abundances (Scaled): F1: 126, Sample, Cortex WT, 1 | Abundances (Scaled): F1: 127, Sample, Cortex WT, 2 | Abundances (Scaled): F1: 128, Sample, Cortex WT, 3 | Abundances (Normalized): F1: 129, Sample, Cortex KO, 1 | Abundances (Normalized): F1: 130, Sample, Cortex KO, 2 | Abundances (Normalized): F1: 131, Sample, Cortex KO, 3 | Abundances (Normalized): F1: 126, Sample, Cortex WT, 1 | Abundances (Normalized): F1: 127, Sample, Cortex WT, 2 | Abundances (Normalized): F1: 128, Sample, Cortex WT, 3 | Abundance: F1: 129, Sample, Cortex KO, 1 | Abundance: F1: 130, Sample, Cortex KO, 2 | Abundance: F1: 131, Sample, Cortex KO, 3 | Abundance: F1: 126, Sample, Cortex WT, 1 | Abundance: F1: 127, Sample, Cortex WT, 2 | Abundance: F1: 128, Sample, Cortex WT, 3 | Abundances Count: F1: 129, Sample, Cortex KO, 1 | Abundances Count: F1: 130, Sample, Cortex KO, 2 | Abundances Count: F1: 131, Sample, Cortex KO, 3 | Abundances Count: F1: 126, Sample, Cortex WT, 1 | Abundances Count: F1: 127, Sample, Cortex WT, 2 | Abundances Count: F1: 128, Sample, Cortex WT, 3 | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Gene Symbol | Chromosome | Reactome Pathways | Ensembl Gene ID | KEGG Pathways | WikiPathways | # Razor Peptides | Modifications |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High | P09055 | Integrin beta-1 OS=Mus musculus OX=10090 GN=Itgb1 PE=1 SV=1 | 0 | 76.632 | 22 | 16 | 21 | 16 | 798 | 88.2 | 5.94 | 0.921 | -0.12 | 0.260218557 | 0.88897849 | 0.2 | 95.9 | 104.1 | 2.41 | 7.8 | 100.3 | 96.5 | 96 | 109 | 104.8 | 93.5 | 1771.9 | 1705 | 1695.5 | 1926.2 | 1851 | 1652.8 | 1661.5 | 1538.9 | 1693.1 | 1724.4 | 1610.8 | 1652.8 | 14 | 14 | 14 | 14 | 14 | 14 | cell differentiation;cell growth;cell organization and biogenesis;cellular component movement;cellular homeostasis;metabolic process;regulation of biological process;response to stimulus;transport | cell surface;cytoplasm;endosome;membrane | metal ion binding;protein binding;receptor activity | "Pf00362, Pf07965, Pf08725" | 16412 | Itgb1 | 8 | ECM proteoglycans; Molecules associated with elastic fibres; Laminin interactions; Integrin cell surface interactions; Localization of the PINCH-ILK-PARVIN complex to focal adhesions; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; MET interacts with TNS proteins; MET activates PTK2 signaling; Signal transduction by L1; Syndecan interactions; Fibronectin matrix formation; Basigin interactions | ENSMUSG00000025809.15 | Leukocyte transendothelial migration; Hypertrophic cardiomyopathy (HCM); Regulation of actin cytoskeleton; Arrhythmogenic right ventricular cardiomyopathy (ARVC); Focal adhesion; Toxoplasmosis; Platelet activation; Small cell lung cancer; Dilated cardiomyopathy; Axon guidance; Cell adhesion molecules (CAMs); Phagosome; Pertussis; Proteoglycans in cancer; Rap1 signaling pathway; Pathways in cancer; ECM-receptor interaction; PI3K-Akt signaling pathway; Leishmaniasis; Bacterial invasion of epithelial cells | PluriNetWork; Signaling of Hepatocyte Growth Factor Receptor; Primary Focal Segmental Glomerulosclerosis FSGS; Focal Adhesion-PI3K-Akt-mTOR-signaling pathway; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; Integrin-mediated Cell Adhesion; Focal Adhesion | 0 |